As of Jun 19
| -0.61 / -3.58%|
The 5 analysts offering 12-month price forecasts for Corcept Therapeutics Inc have a median target of 30.00, with a high estimate of 32.00 and a low estimate of 6.00. The median estimate represents a +84.33% increase from the last price of 16.27.
The current consensus among 5 polled investment analysts is to Buy stock in Corcept Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.